Investor Presentaiton
Investor presentation
ADA 2019
Slide 22
Connected insulin pen resulting in improved adherence and
'time in range' in Swedish study
Novo PenⓇ 6 with Glooko/DiasendⓇ system
More accurate data leading to better doctor-
patient conversations and treatment results
1. NovoPenⓇ 6
2. Data
capture
3. Data
storage
glooko
HCP
In-clinic data box
6.2
Patient
4. HCP
review of data
glooko
43% fewer missed meal-time
insulin injections
28% increase in dose of meal-
time insulin
FGM/CGM blood
glucose data
Storage of
data on cloud
Visualisation of
patient data
(insulin dosing and
glucose data) on
same interface
using HCP platform
Anonymised data transfer to Novo Nordisk for
research and product development purposes
For more details, see ADA 2019 Late-breaking poster presentation 126-LB and Poster presentation
1076-P; HCP: healthcare professional; FGM: flash glucose monitor; CGM: continuous glucose monitor
2 more hours in good glucose
control per person per day
novo nordiskView entire presentation